New Drug Review

Tisagenlecleucel (Kymriah) for Acute Lymphoblastic Leukemia
Tisagenlecleucel (Kymriah) for Acute Lymphoblastic LeukemiaA new era of treatment has arrived—here’s what you need to know.
New Drug Review: Sarilumab
New Drug Review: SarilumabThe FDA approved Kevzara for RA patients.
New Drug ReviewPlecanatide: Approved for Chronic Idiopathic Constipation
FDA Approves Rucaparib for Advanced Ovarian Cancer
FDA Approves Rucaparib for Advanced Ovarian CancerThe New Drug Review for April